3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
7
Leukemia, Biphenotypic, Acute
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoma, Large B-Cell, Diffuse
2
Hematologic Neoplasms
2
Prostatic Neoplasms
1
Pneumonia
1
Neoplasms
1
Neoplasm Metastasis
1
Lymphoma, Follicular
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma
1
Lymphohistiocytosis, Hemophagocytic
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hepatectomy
1
Drug-Related Side Effects and Adverse Reactions
1
Down Syndrome
1
Brain Neoplasms
1
Blastic Plasmacytoid Dendritic Cell Neoplasm
1
Acute Gout
1
Interventions
X-Rays
9
Specimen Handling
8
Phantoms, Imaging
8
Magnetic Resonance Spectroscopy
8
Vincristine
5
Nuclear Medicine Department, Hospital
5
Biopsy
5
Doxorubicin
4
Etoposide
3
Dactinomycin
3
Cyclophosphamide
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
Temozolomide
2
Radiotherapy, Conformal
2
Radiotherapy
2
Radiation
2
LY3023414
2
Irinotecan
2
talazoparib
1
selinexor
1
pembrolizumab
1
olaparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Wilms Tumor
×
Methylprednisolone
×
90 days
×
Clear all
No trials found.